These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26697756)

  • 1. Diabetes and Glucose Metabolism in Thalassemia Major: An Update.
    De Sanctis V; Soliman AT; Elsedfy H; Pepe A; Kattamis C; El Kholy M; Yassin M
    Expert Rev Hematol; 2016; 9(4):401-8. PubMed ID: 26697756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes mellitus in Chinese children with thalassaemia major.
    Liang Y; Bajoria R; Jiang Y; Su H; Pan H; Xia N; Chatterjee R; Lai Y
    Trop Med Int Health; 2017 Jun; 22(6):716-724. PubMed ID: 28544032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concept in natural history and management of diabetes mellitus in thalassemia major.
    Chatterjee R; Bajoria R
    Hemoglobin; 2009; 33 Suppl 1():S127-30. PubMed ID: 20001615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
    Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
    Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modifiers of secondary iron overload in beta thalassemia major.
    Athiyarath R; George B; Abraham A; Viswabandya A; Srivastava A; Edison ES
    Blood Cells Mol Dis; 2015 Mar; 54(3):242-3. PubMed ID: 25601433
    [No Abstract]   [Full Text] [Related]  

  • 6. History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major.
    Ang AL; Tzoulis P; Prescott E; Davis BA; Barnard M; Shah FT
    Eur J Haematol; 2014 Mar; 92(3):229-36. PubMed ID: 24164584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
    Pennell DJ; Udelson JE; Arai AE; Bozkurt B; Cohen AR; Galanello R; Hoffman TM; Kiernan MS; Lerakis S; Piga A; Porter JB; Walker JM; Wood J;
    Circulation; 2013 Jul; 128(3):281-308. PubMed ID: 23775258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
    Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
    Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N
    Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
    Saliba AN; El Rassi F; Taher AT
    Expert Rev Hematol; 2016; 9(2):151-68. PubMed ID: 26613264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major.
    Meloni A; Nobile M; Keilberg P; Positano V; Santarelli MF; Pistoia L; Spasiano A; Casini T; Putti MC; Cuccia L; Bitti PP; Messina G; Peritore G; Renne S; Grassedonio E; Quaia E; Cademartiri F; Pepe A
    Eur Radiol; 2023 Oct; 33(10):7215-7225. PubMed ID: 37115218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the influence of iron overload in glucose metabolism in thalassemia major patients].
    Liang LY; Lao WQ; Meng Z; Zhang LN; Hou LL; Ou H; Liu ZL; He ZW; Luo XY; Fang JP
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):419-422. PubMed ID: 28592008
    [No Abstract]   [Full Text] [Related]  

  • 15. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
    Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
    Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
    Kurtoglu AU; Kurtoglu E; Temizkan AK
    Endokrynol Pol; 2012; 63(4):260-3. PubMed ID: 22933160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of glucose dysregulation and the relationship with iron overload in Chinese children with beta thalassemia major.
    Zhang L; Meng Z; Jiang Z; Liu Z; Hou L; Cai G; Ou H; Huang S; Song Q; Fang J; Liang L
    Pediatr Diabetes; 2022 Aug; 23(5):562-568. PubMed ID: 34453777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients.
    Shaw J; Chakraborty A; Nag A; Chattopadyay A; Dasgupta AK; Bhattacharyya M
    Eur J Haematol; 2017 Nov; 99(5):399-408. PubMed ID: 28815805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.
    Pepe A; Meloni A; Rossi G; Caruso V; Cuccia L; Spasiano A; Gerardi C; Zuccarelli A; D'Ascola DG; Grimaldi S; Santodirocco M; Campisi S; Lai ME; Piraino B; Chiodi E; Ascioti C; Gulino L; Positano V; Lombardi M; Gamberini MR
    Br J Haematol; 2013 Nov; 163(4):520-7. PubMed ID: 24111905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of deferasirox in β-thalassemia major patients in Iran: a prospective study from a single referral center in Iran.
    Alavi S; Ebadi M; Ghazizadeh F; Arzanian MT; Shamsian B; Abdollah Gorji F
    Pediatr Hematol Oncol; 2014 Feb; 31(1):76-86. PubMed ID: 24383712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.